Metalis Lifesciences Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 23-10-2024
- Paid Up Capital ₹ 0.10 M
as on 23-10-2024
- Company Age 5 Year, 10 Months
- Last Filing with ROC 31 Mar 2023
- Revenue 46.68%
(FY 2023)
- Profit 1497.01%
(FY 2023)
- Ebitda 705.64%
(FY 2023)
- Net Worth 376.30%
(FY 2023)
- Total Assets 41.11%
(FY 2023)
About Metalis Lifesciences
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Ajay Mishra, Ajaykumar Maurya, Pankaj Tiwari, and Three other members serve as directors at the Company.
- CIN/LLPIN
U24100MH2019PTC322484
- Company No.
322484
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
13 Mar 2019
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Thane, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Metalis Lifesciences Private Limited offer?
Metalis Lifesciences Private Limited offers a wide range of products and services, including Vitamins & Supplements, Mineral Supplements.
Who are the key members and board of directors at Metalis Lifesciences?
Board Members(6)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ajay Mishra  | Director | 13-Mar-2019 | Current |
| Ajaykumar Maurya | Director | 13-Mar-2019 | Current |
| Pankaj Tiwari | Director | 13-Mar-2019 | Current |
| Ganesh Mishra | Additional Director | 28-Sep-2020 | Current |
| Laxmikant Rokade | Additional Director | 28-Sep-2020 | Current |
| Arvind Yadav | Additional Director | 28-Sep-2020 | Current |
Financial Performance of Metalis Lifesciences.
Metalis Lifesciences Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 46.68% increase. The company also saw a substantial improvement in profitability, with a 1497.01% increase in profit. The company's net worth Soared by an impressive increase of 376.3%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Metalis Lifesciences?
In 2023, Metalis Lifesciences had a promoter holding of 76.00% and a public holding of 24.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Metalis Lifesciences?
Metalis Lifesciences has a workforce of 36 employees as of Mar 24, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Metalis Lifesciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Metalis Lifesciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
